Enhanced Safety Laser Hair Removal System
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00441948|
Recruitment Status : Unknown
Verified February 2007 by Scilex Ltd..
Recruitment status was: Not yet recruiting
First Posted : March 1, 2007
Last Update Posted : March 1, 2007
|Condition or disease||Intervention/treatment||Phase|
|Hirsutism Hypertrichosis||Device: Peterio||Not Applicable|
Lasers are a well-established, popular modality for removal of unwanted hair. The existing lasers are based on a wavelength that is specifically absorbed by the pigment melanin found in the hair follicle, where the energy is converted to heat resulting in a thermal injury.
However, lasers for hair removal are not without limitations. A laser based long-term hair removal treatment is based on thermal destruction of the hair shaft and follicle using wavelengths that are specifically absorbed by the pigment melanin found in the hair follicle. The heating of hair follicle is done through heat dissipation from the hair shaft. One of the significant limitations of this approach is the fact that the epidermis through which the light energy must penetrate is rich in melanin and therefore absorbs a major portion of the energy, resulting in inadequate heating of the hair follicles. The purpose of the study is an evaluation safety and efficacy of a new laser based device.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||10 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Peterio™ – an Add-on Device for Enhanced Safety of Aesthetic Laser Treatments.|
|Study Start Date :||May 2007|
|Study Completion Date :||April 2008|
- Hair reduction as counted 1-3 months after each treatment session, depending on the treated area.
- Long term clearance will be calculated as the ratio between the value of the baseline hair count taken immediately before the first treatment, and the value obtained at the 3-6 month post treatment hair count.
- Measuring treatment discomfort as graded by the patients.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00441948
|Contact: Leon Gilad, MDfirstname.lastname@example.org|
|Hadassah Medical Center, Dermatology||Not yet recruiting|
|Jerusalem, Israel, 91120|
|Principal Investigator: Leon Gilad, MD|
|Principal Investigator:||Leon Gilad, MD||Hadassah Medical Organization|